Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03215667 · ClinicalTrials.gov registry record · NA
Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites
A NA study, sponsored by Sunstar Americas.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03215667: Clinical Trial NA study, sponsored by Sunstar Americas.
NCT03215667 is a NA study that was terminated before completion, run by Sunstar Americas. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03215667, a NA study, was terminated before completion, sponsored by Sunstar Americas.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Purpose of the single arm study is to clinically and histologically evaluate alloplastic in-situ hardening, moldable beta-tricalcium phosphate(TCP) bone graft material and polylactide membrane in alveolar ridge preservation following extraction of non-molar teeth with non-containable extraction sockets.
Primary Outcome
Cone-beam computed tomography (CBCT) was taken at the ridge preservation procedure (baseline) and 3 months after the procedure. The horizontal ridge width was measured at 1, 3, 5 and 7 mm below the alveolar bone crest. Overall change is the average of all measurements.
Interventions
- DEVICE easy-graft CLASSIC (beta-Tricalcium Phosphate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2019-11-03 |
| Phase | NA |
Why NCT03215667 stopped before completion
NCT03215667 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which easy-graft CLASSIC (beta-Tricalcium Phosphate) is the first listed.
NCT03215667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03215667 about?
NCT03215667 is a clinical study titled "Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites". Purpose of the single arm study is to clinically and histologically evaluate alloplastic in-situ hardening, moldable beta-tricalcium phosphate(TCP) bone graft material and polylactide membrane in alveolar ridge preservation following extraction of non-molar teeth with non-containable extraction sock...
What is the current status of trial NCT03215667?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2017-08-01. Estimated completion is 2019-11-03.
What interventions are being tested in trial NCT03215667?
The interventions under investigation include: easy-graft CLASSIC (beta-Tricalcium Phosphate) (DEVICE).
Who is sponsoring clinical trial NCT03215667?
This trial is sponsored by Sunstar Americas, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03215667's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI